Revenue
1.63 million USD
2023 Q2 · USD
Exact inputs and evidence
- Revenue: 1627031 USD Source
73 filing records in this dataset, filed from 2015-03-23 to 2026-10-26. Reported financial figures are available; chart coverage varies by period.
1.63 million USD
2023 Q2 · USD
-221.37%
2023 Q2 · %
-2.93 million USD
2023 Q2 · USD
-2.98 million USD
2023 Q2 · USD
577328 USD
15606 USD
20234993 shares
1,137.25% · 18.6 million shares
Year-over-year change in reported shares. Splits, issuance and buybacks can affect this figure; it does not isolate employee compensation or economic dilution.
The four most recent complete quarters added together. This gives a full-year view that includes the latest quarterly results.
6.07 million USD
2022-07-01 – 2023-06-30
-22.9 million USD
2025-07-01 – 2026-06-30
-12.2 million USD
2025-07-01 – 2026-06-30
348 thousand USD
2022-07-01 – 2023-06-30
Includes later revisions to earlier periods. Annual charts exclude incomplete years.
Latest filing recorded: 2026-10-26.
Financial data available through: 2025-12-31.
Coverage describes values retained in this snapshot. Missing values are not zero; loading limits are reported separately.
Latest complete year compared with the corresponding period one year earlier. These are measured changes; they do not establish their business causes.
Prior period
−USD 6.26 million
–
Current period
−USD 16.97 million
–
-16965875 − -6259191 = -10706684 USD
-6259191 USD · 2024-01-01 – 2024-12-31
Inspect prior input Prior source-16965875 USD · 2025-01-01 – 2025-12-31
Inspect current input Current sourceThe citation records this snapshot. The page link may show a newer release later.
Prior period
−USD 6.33 million
–
Current period
−USD 6.95 million
–
-6951458 − -6327503 = -623955 USD
-6327503 USD · 2024-01-01 – 2024-12-31
Inspect prior input Prior source-6951458 USD · 2025-01-01 – 2025-12-31
Inspect current input Current sourceThe citation records this snapshot. The page link may show a newer release later.
Comparable inputs unavailable for: Revenue, Capital expenditure.
How a period’s revenue divides into costs and what remains as profit. Items marked Derived are calculated by subtraction from reported figures.
| Period | Revenue | Operating costs | Operating income | Tax, interest and other | Net income | Free cash flow | Source |
|---|---|---|---|---|---|---|---|
| 2020 2020-01-01 – 2020-12-31 | 4306316 | Unavailable | Unavailable | Unavailable | -20421979 | Unavailable | Source
|
| 2021 2021-01-01 – 2021-12-31 | 5653725 | 28316761 Derived | -22663036 | -4765899 Derived | -17897137 | -14834471 Derived | Source
|
| 2022 2022-01-01 – 2022-12-31 | 4983556 | 19744276 Derived | -14760720 | 3879823 Derived | -18640543 | -13364684 Derived | Source
|
Amounts are exact, in USD.
Sales over time and how quickly they are changing.
Revenue reported for each complete financial period.
| Period | Series | Value(USD) | Source evidence |
|---|---|---|---|
| 2020 | Revenue | 4306316 |
|
| 2021 | Revenue | 5653725 |
|
| 2022 | Revenue | 4983556 |
|
Change in revenue from the same financial period one year earlier.
| Period | Series | Value | Source evidence |
|---|---|---|---|
| 2020 | Year over year | No prior comparable period |
|
| 2021 | Year over year | 31.3% |
|
| 2022 | Year over year | -11.9% |
|
How much revenue becomes profit, and how much cash operations generate.
Operating income, net income and free cash flow as a share of revenue.
| Period | Series | Value | Source evidence |
|---|---|---|---|
| 2020-12-31 | Operating margin | Not reported |
|
| 2021 | Operating margin | -400.9% |
|
| 2022 | Operating margin | -296.2% |
|
| 2020 | Net margin | -474.2% |
|
| 2021 | Net margin | -316.6% |
|
| 2022 | Net margin | -374% |
|
| 2020 | Free cash flow margin | Not reported |
|
| 2021 | Free cash flow margin | -262.4% |
|
| 2022 | Free cash flow margin | -268.2% |
|
Cash generated by the company’s normal business operations.
| Period | Series | Value(USD) | Source evidence |
|---|---|---|---|
| 2020 | Operating cash flow | Not reported | No source recorded |
| 2021 | Operating cash flow | -14700000 |
|
| 2022 | Operating cash flow | -13200000 |
|
Operating cash flow minus capital expenditure for the same period and unit.
| Period | Series | Value(USD) | Source evidence |
|---|---|---|---|
| 2020 | Free cash flow | Unavailable | No source recorded |
| 2021 | Free cash flow | -14834471 |
|
| 2022 | Free cash flow | -13364684 |
|
Liabilities and short-term ability to meet obligations at each period end.
Total liabilities as a share of total assets.
| Period | Series | Value | Source evidence |
|---|---|---|---|
| 2020 | Liabilities / assets | 37.2% |
|
| 2021 | Liabilities / assets | 27.5% |
|
| 2022 | Liabilities / assets | 54.1% |
|
Current assets divided by current liabilities.
| Period | Series | Value | Source evidence |
|---|---|---|---|
| 2020 | Current assets / current liabilities | 2.71× |
|
| 2021 | Current assets / current liabilities | 4.49× |
|
| 2022 | Current assets / current liabilities | 1.26× |
|
Compare reported profit with operating cash and capital spending. Free cash flow is calculated as operating cash flow minus capital expenditure when both exact, consolidated amounts match the same period and unit.
| Period | Net income | Operating cash flow | Capital expenditure | Free cash flow |
|---|---|---|---|---|
| 2016 2016-01-01 – 2016-12-31 | −USD 18.38 million Exact valueExact value: -18384634 USD Share or citeThe citation records this snapshot. The page link may show a newer release later. | −USD 15.21 million Exact valueExact value: -15208718 USD Share or citeThe citation records this snapshot. The page link may show a newer release later. | USD 8,063 Exact valueExact value: 8063 USD Share or citeThe citation records this snapshot. The page link may show a newer release later. | −USD 15.22 million Calculation and evidence-15208718 − 8063 USD Exact free cash flow: -15216781 USD
Share or citeThe citation records this snapshot. The page link may show a newer release later. |
| 2017 2017-01-01 – 2017-12-31 | −USD 7.86 million Exact valueExact value: -7863858 USD Share or citeThe citation records this snapshot. The page link may show a newer release later. | −USD 7.4 million Exact valueExact value: -7397912 USD Share or citeThe citation records this snapshot. The page link may show a newer release later. | USD 7,678 Exact valueExact value: 7678 USD Share or citeThe citation records this snapshot. The page link may show a newer release later. | −USD 7.41 million Calculation and evidence-7397912 − 7678 USD Exact free cash flow: -7405590 USD
Share or citeThe citation records this snapshot. The page link may show a newer release later. |
| 2018 2018-01-01 – 2018-12-31 | −USD 16.87 million Exact valueExact value: -16868711 USD Share or citeThe citation records this snapshot. The page link may show a newer release later. | −USD 13.33 million Exact valueExact value: -13332927 USD Share or citeThe citation records this snapshot. The page link may show a newer release later. | USD 2,008 Exact valueExact value: 2008 USD Share or citeThe citation records this snapshot. The page link may show a newer release later. | −USD 13.33 million Calculation and evidence-13332927 − 2008 USD Exact free cash flow: -13334935 USD
Share or citeThe citation records this snapshot. The page link may show a newer release later. |
| 2019 2019-01-01 – 2019-12-31 | −USD 10.13 million Exact valueExact value: -10133019 USD Share or citeThe citation records this snapshot. The page link may show a newer release later. | −USD 14.52 million Exact valueExact value: -14516690 USD Share or citeThe citation records this snapshot. The page link may show a newer release later. | USD 1,589 Exact valueExact value: 1589 USD Share or citeThe citation records this snapshot. The page link may show a newer release later. | −USD 14.52 million Calculation and evidence-14516690 − 1589 USD Exact free cash flow: -14518279 USD
Share or citeThe citation records this snapshot. The page link may show a newer release later. |
| 2020 2020-01-01 – 2020-12-31 | −USD 20.42 million Exact valueExact value: -20421979 USD Share or citeThe citation records this snapshot. The page link may show a newer release later. | Unavailable Not reported for this period. | Unavailable Not reported for this period. | Unavailable Free cash flow cannot be calculated because Operating cash flow + Capital expenditure is unavailable for this period. |
| 2021 2021-01-01 – 2021-12-31 | −USD 17.9 million Exact valueExact value: -17897137 USD Share or citeThe citation records this snapshot. The page link may show a newer release later. | −USD 14.7 million Exact valueExact value: -14700000 USD Share or citeThe citation records this snapshot. The page link may show a newer release later. | USD 134,471 Exact valueExact value: 134471 USD Share or citeThe citation records this snapshot. The page link may show a newer release later. | −USD 14.83 million Calculation and evidence-14700000 − 134471 USD Exact free cash flow: -14834471 USD
Share or citeThe citation records this snapshot. The page link may show a newer release later. |
| 2022 2022-01-01 – 2022-12-31 | −USD 18.64 million Exact valueExact value: -18640543 USD Share or citeThe citation records this snapshot. The page link may show a newer release later. | −USD 13.2 million Exact valueExact value: -13200000 USD Share or citeThe citation records this snapshot. The page link may show a newer release later. | USD 164,684 Exact valueExact value: 164684 USD Share or citeThe citation records this snapshot. The page link may show a newer release later. | −USD 13.36 million Calculation and evidence-13200000 − 164684 USD Exact free cash flow: -13364684 USD
Share or citeThe citation records this snapshot. The page link may show a newer release later. |
| 2023 2023-01-01 – 2023-12-31 | −USD 13.42 million Exact valueExact value: -13417212 USD Share or citeThe citation records this snapshot. The page link may show a newer release later. | −USD 10.3 million Exact valueExact value: -10304263 USD Share or citeThe citation records this snapshot. The page link may show a newer release later. | Unavailable Not reported for this period. | Unavailable Free cash flow cannot be calculated because Capital expenditure is unavailable for this period. |
| 2024 2024-01-01 – 2024-12-31 | −USD 6.26 million Exact valueExact value: -6259191 USD Share or citeThe citation records this snapshot. The page link may show a newer release later. | −USD 6.33 million Exact valueExact value: -6327503 USD Share or citeThe citation records this snapshot. The page link may show a newer release later. | Unavailable Not reported for this period. | Unavailable Free cash flow cannot be calculated because Capital expenditure is unavailable for this period. |
| 2025 2025-01-01 – 2025-12-31 | −USD 16.97 million Exact valueExact value: -16965875 USD Share or citeThe citation records this snapshot. The page link may show a newer release later. | −USD 6.95 million Exact valueExact value: -6951458 USD Share or citeThe citation records this snapshot. The page link may show a newer release later. | Unavailable Not reported for this period. | Unavailable Free cash flow cannot be calculated because Capital expenditure is unavailable for this period. |
Capital expenditure uses the canonical mapped positive-spending convention. A missing, ambiguous, incompatible, or negative-sign input is left blank. Values use the latest reported version.
Coverage reflects filings processed into this Fundies dataset; it does not imply every source filing is loaded.
73 filings · 2,702 latest values · 2,702 originally reported values
Dataset published . Source filing dates and reporting periods are shown separately.
Identifiers: 0001460702, 1460702, AIXC, FFR, QLGN, RTTR, edgar:1460702
Also known as AIxCrypto Holdings, Inc., FF EAI Robotics Ecosystem Inc., Qualigen Therapeutics, Inc., Qualigen Therapeutics, Inc., RITTER PHARMACEUTICALS INC